Related Experiment Videos
Some cardiovascular effects of cyclocytidine
Cancer Treatment Reports
|November 1, 1976
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity.
Cancer chemotherapy and pharmacology·2001
Cardiovascular effects of buccal exposure to dermal nicotine patches in the dog: a comparative evaluation.
Journal of toxicology. Clinical toxicology·2001
Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
Cancer chemotherapy and pharmacology·2001
Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1999
Preclinical animal models of cardiac protection from anthracycline-induced cardiotoxicity.
Seminars in oncology·1998
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987